0001562180-16-003141.txt : 20160914 0001562180-16-003141.hdr.sgml : 20160914 20160914091416 ACCESSION NUMBER: 0001562180-16-003141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160912 FILED AS OF DATE: 20160914 DATE AS OF CHANGE: 20160914 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dermira, Inc. CENTRAL INDEX KEY: 0001557883 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273267680 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 275 MIDDLEFIELD ROAD STREET 2: SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650 421 7200 MAIL ADDRESS: STREET 1: 275 MIDDLEFIELD ROAD STREET 2: SUITE 150 CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GUGGENHIME ANDREW CENTRAL INDEX KEY: 0001230724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36668 FILM NUMBER: 161884282 MAIL ADDRESS: STREET 1: 3061 ZANKER RD CITY: SAN JOSE STATE: CA ZIP: 95134 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-09-12 false 0001557883 Dermira, Inc. DERM 0001230724 GUGGENHIME ANDREW C/O DERMIRA, INC. 275 MIDDLEFIELD ROAD, SUITE 150 MENLO PARK CA 94025 false true false false COO and CFO Common Stock 2016-09-12 4 M false 10000.00 5.51 A 15116.00 D Common Stock 2016-09-12 4 S false 10000.00 32.53 D 5116.00 D Employee Stock Options (Right to buy) 5.51 2016-09-12 4 M false 10000.00 0.00 D 2024-06-04 Common Stock 10000.00 150513.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $32.30 to $32.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These shares include prior ESPP purchases. 25% of the total shares underlying the option vested and became exercisable on May 1, 2015 and 1/48 of the total shares underlying the option vest and become exercisable each month thereafter, subject to the continuing employment of the Reporting person on the applicable vesting date. /s/ Christine Ring, by power of attorney 2016-09-13